Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Retrospective database analysis
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged 18 years and over at the time of diagnosis;
Patients from the BSRBR with moderate RA as defined by a DAS28 (\>3.2 and ≤5.1);
Patients who have given informed consent for long term follow-up and access to all medical records;
Patients initiating (i.e. at leats one treatment) treatment with etanercept (Enbrel) for RA.
The Control Group:
Patients aged 18 years and over a the time of diagnosis;
Patients from the BSRBR with moderate RA as defined by a DAS28 (\>3.2 and ≤5.1);
Patients who have given informed consent for long term follow-up and access to all medical records; Patients are receiving at least one traditional DMARD and have never been prescribed a biologic agent;
You may not be if
Per BSRBR registry since data is retropsectively being analyzed
Clareo Health | Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
